Form 4 for DBVT DBV Technologies S.A.
Accepted 2026-07-31 16:15:05 ET · period of report 2026-07-29 · accession 0001760395-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 16:15 | 2026-07-29 | DBVT | Mohideen Pharis | Chief Medical Off | S - Sale | $2.70 | -464 | 144.5K | -0.3% | -$1,253 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-07-29 | S | D | 464 | $2.70 | 144,531 | D | — | — | (F1) The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares. (F2) Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units. (F3) This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1380 to EURO 1.00 as of July 29, 2026. |